Divine Aleru, Microbiome Medicine Research Coordinator

This study demonstrates the effectiveness of ultrasound-guided hUC-MSC exosome injection in restoring ovarian function and fertility in POI rat models, offering a new therapeutic approach for women with POI.

This study demonstrates that metformin protects against chemotherapy-induced ovarian failure by reducing inflammation, oxidative stress, and senescence in granulosa cells via the AMPK/PPAR-γ/SIRT1 pathway.

The review discusses the therapeutic use of hormone replacement therapy (HRT) for managing POI and early menopause, highlighting its benefits in preventing complications like osteoporosis, cardiovascular disease, and depression.

Amsel’s Criteria is a clinically established diagnostic method for bacterial vaginosis, offering a practical and accessible alternative to laboratory-based approaches. It evaluates four key clinical indicators, ensuring timely diagnosis and intervention in outpatient settings.

This study identifies 27 metabolites linked to primary ovarian insufficiency (POI), revealing novel metabolic pathways and offering insights into POI biomarkers and therapeutic targets.

This study identifies 33 serum metabolites, including N-acetylalanine, linked to an increased risk of primary ovarian insufficiency (POI), offering new insights into the disease’s genetic and metabolic causes.

This study identifies metabolic disruptions in POI, including altered amino acid and lipid metabolism. Key metabolites such as acetoacetate and HDCA were found to be potential biomarkers, shedding light on the oxidative stress and mitochondrial dysfunction involved in POI.

This study examines the metabolic profile of women with premature ovarian insufficiency, finding significant changes in lipid and glucose metabolism. The results underscore the importance of early metabolic screening and management to reduce cardiovascular and metabolic risks associated with POI.

This study investigates the metabolic differences in women with premature ovarian insufficiency (POI), highlighting increased waist circumference, cholesterol, and glucose levels. It underscores the importance of early metabolic screening and management to address the elevated cardiovascular risk associated with POI.

This study identifies key metabolites altered in premature ovarian insufficiency (POI), including arachidonoyl amide and 18-HETE, which could serve as diagnostic biomarkers. The findings reveal insights into the metabolic disturbances of POI, offering potential therapeutic directions.

This study explores the potential link between serum heavy metal levels and premature ovarian insufficiency. The higher levels of metals like lead and mercury in women with POI suggest environmental toxins may contribute to ovarian dysfunction, though the findings were not statistically significant.

This review highlights the impact of heavy metal-induced oxidative stress on ovarian function, contributing to premature ovarian insufficiency. It discusses the mechanisms by which metals like copper, arsenic, and cadmium induce ROS, leading to ovarian damage, and the potential therapeutic role of antioxidants.

Tobacco smoke significantly impacts ovarian function, leading to premature ovarian insufficiency. The review outlines the harmful effects of various tobacco-related toxins, such as nicotine, cadmium, and PAHs, and the associated reproductive consequences, including early menopause and reduced fertility.

The review explores the potential of dietary supplements, including probiotics and phytoestrogens, to manage premature ovarian insufficiency (POI) symptoms. It highlights the safety, bioavailability, and efficacy of these nutrients for improving reproductive health and delaying ovarian function decline.

This study identifies dietary habits that influence the risk of Primary Ovarian Insufficiency (POI), finding that high-fat dairy products increase risk while oily fish and pork offer protection, suggesting that dietary interventions could help prevent POI.

The study reveals a distinct gut microbiome profile in women with premature ovarian insufficiency (POI), with altered bacterial populations linked to hormonal changes, suggesting a potential role of the microbiome in POI pathogenesis and management.

The study reveals that women with premature ovarian insufficiency on systemic hormone therapy maintain a Lactobacillus-dominated vaginal microbiome, similar to estrogenized women, though some show signs of bacterial vaginosis, indicating the influence of factors beyond estrogen.

This study identifies significant differences in vaginal microbiota between women with premature ovarian insufficiency (POI) and healthy controls, suggesting that microbial shifts could contribute to ovarian dysfunction and hormone imbalances in POI.

The review examines how lifestyle factors like diet, exercise, and oxidative stress contribute to Premature Ovarian Insufficiency (POI) and explores potential interventions using antioxidants, phytoestrogens, and dietary changes.

This review provides a comprehensive look at the genetic and phenotypic aspects of Premature Ovarian Insufficiency (POI), emphasizing the roles of various genes and chromosomal abnormalities, and offering insights into personalized treatment options and future research directions.

This review explores the causes, clinical presentation, and management of Premature Ovarian Insufficiency (POI), highlighting the role of genetic, autoimmune, and environmental factors, and discusses advancements in fertility preservation and hormone replacement therapy.

This review investigates the genetic and non-genetic causes of Premature Ovarian Insufficiency (POI), highlighting recent advances in understanding its mechanisms and exploring novel therapeutic approaches such as hormone replacement therapy and stem cell treatments.

This review explores the genetic and clinical factors contributing to primary ovarian insufficiency (POI), highlighting key genes and the importance of early diagnosis, fertility preservation, and hormone replacement therapy.

Premature ovarian insufficiency (POI) leads to fertility issues, bone loss, cardiovascular risks, and cognitive decline. Early intervention, including hormone therapy and lifestyle changes, is vital for managing long-term health risks.